Veradermics, Inc. (MANE)
142.30
+3.52
(+2.54%)
USD |
NYSE |
Nov 09, 10:37
Veradermics Market Cap : 5.945B for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 5.798B |
| November 05, 2026 | 5.373B |
| November 04, 2026 | 5.703B |
| November 03, 2026 | 5.582B |
| November 02, 2026 | 5.412B |
| October 30, 2026 | 5.836B |
| October 29, 2026 | 6.010B |
| October 28, 2026 | 6.009B |
| October 27, 2026 | 5.879B |
| October 26, 2026 | 5.740B |
| October 23, 2026 | 5.798B |
| October 22, 2026 | 5.786B |
| October 21, 2026 | 5.710B |
| October 20, 2026 | 5.311B |
| October 19, 2026 | 5.109B |
| October 16, 2026 | 4.547B |
| October 15, 2026 | 4.808B |
| October 14, 2026 | 4.741B |
| October 13, 2026 | 4.857B |
| October 12, 2026 | 5.114B |
| October 09, 2026 | 5.469B |
| October 08, 2026 | 5.291B |
| October 07, 2026 | 4.636B |
| October 06, 2026 | 4.552B |
| October 05, 2026 | 4.966B |
| Date | Value |
|---|---|
| October 02, 2026 | 4.878B |
| October 01, 2026 | 4.897B |
| September 30, 2026 | 5.065B |
| September 29, 2026 | 4.923B |
| September 28, 2026 | 4.805B |
| September 25, 2026 | 4.870B |
| September 24, 2026 | 4.835B |
| September 23, 2026 | 4.837B |
| September 22, 2026 | 4.936B |
| September 21, 2026 | 4.713B |
| September 18, 2026 | 4.460B |
| September 17, 2026 | 4.541B |
| September 16, 2026 | 4.279B |
| September 15, 2026 | 4.341B |
| September 14, 2026 | 4.249B |
| September 11, 2026 | 4.135B |
| September 10, 2026 | 4.100B |
| September 09, 2026 | 4.164B |
| September 08, 2026 | 4.338B |
| September 04, 2026 | 4.116B |
| September 03, 2026 | 4.084B |
| September 02, 2026 | 4.114B |
| September 01, 2026 | 4.074B |
| August 31, 2026 | 4.112B |
| August 28, 2026 | 4.092B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.316T |
| ANI Pharmaceuticals, Inc. | 1.567B |
| Corcept Therapeutics, Inc. | 8.040B |
| Veru, Inc. | 37.17M |
| Johnson & Johnson | 668.67B |
Market Cap Related Metrics
| PEG Ratio | -0.1549 |
| Price to Book Value | 7.302 |
| Price | 142.30 |
| Earnings Yield | -1.83% |
| PEGY Ratio | -0.1549 |